LQDA
Liquidia Corporation
Drug Manufacturers - Specialty & Generic · Healthcare · United States
72.10
close · 2026-08-13
value
8
cheaper than peers8
quality
96
stronger fundamentals96
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 12.45× | 54 |
| price to book | 58.62× | 9 |
| EV to EBITDA | 167.12× | 2 |
| price to sales | 24.32× | 2 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 4158.5% | 98 |
| operating margin | 46.3% | 96 |
| return on equity | 28.2% | 88 |
| debt to equity | 170.2% | 33 |
4 of 4 measures available
Facts
| market cap | $6B |
| free cash flow | $9.6M |
| employees | 216 |
| first trade | 2018-07-26 |
| next earnings | 2026-08-12 |
| fundamentals updated | 2026-08-12 |